Connect with us

Legal & Regulation

DEA Court Ordered to Explain Marijuana Research Delays for Scottsdale Research Institute (SRI)



DEA Still Working on Marijuana Growing Applications as Senators Request Status Updates

The Department of Justice and Drug Enforcement Agency received a letter from Congressional Members in May 2019, urging them to “do more to speed research on the medical benefits of cannabis.” The letter continues, “We urge you then to go beyond these steps and do whatever you can to speed up and improve the research application process.” According to the letter, there were 26 spending applications to grow cannabis for research, as of the time of the letter.

It appears that the DEA has not acted on the letter. The Scottsdale Research Institute, based in Arizona, filed a Writ of Mandamus (later amended) requesting that the court order the agency to process applications faster. The petition alleges, in part, “At this juncture, nothing short of a writ from this Court compelling the agency to act will stop the ongoing harm caused by the DEA’s unlawful and unreasonable delay.” alleging unlawful failure to act on research applications for medical cannabis that had been filed in 2016.

The U.S. Court of Appeals for the D.C. Circuit issued an Order on Monday as to the amended petition, requiring the DEA to,

“file a response to the amended mandamus petition, not to exceed 7,800 words, within 30 days of the date of this order.”

Marijuana Moment reported that The Scottsdale Research Institute stated in a press release, “Despite publicly soliciting applications back in August of 2016, DEA has acted none of them,” SRI said in a press release. “It has never offered any coherent explanation for this delay, other than to say it is still working through the process and these applications are still under review.” The press release reportedly continued, “Hopefully, DEA will finally explain, in a court-filing available for public inspection, the answer to this question that has frustrated everyone.” The DEA has the authority to enforce the federal prohibition on marijuana. Under federal law, marijuana is illegal and is classified as a Schedule I drug.

All information is for general informational and educational purposes only. Nothing should be interpreted as legal or wellness advice.

Jane is a regular contributor who learned about the great benefits of CBD a few years ago after starting it herself. Impressed by its effects, she's interested in helping others learn about options that can be helpful for them.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.